Medinice S.A Asset Resilience Ratio
Medinice S.A asset resilience ratio. Medinice S.A (ICE) has an Asset Resilience Ratio of 4.79% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Medinice S.A (ICE) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Medinice S.A (2017–2023)
Asset resilience ratio of Medinice S.A from 2017 to 2023. This chart shows how Medinice S.A's Asset Resilience Ratio has changed over time. Read Medinice S.A debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Medinice S.A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Medinice S.A.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 0% |
| Short-term Investments | zł1.69 Million | 4.79% |
| Total Liquid Assets | zł1.69 Million | 4.79% |
Asset Resilience Insights
- Limited Liquidity: Medinice S.A maintains only 4.79% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Medinice S.A Industry Peers by Asset Resilience Ratio
Compare Medinice S.A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
TAIDOC TECHNOLOGY CORP
TW:4736 |
Medical Devices | 23.03% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 3.90% |
Medinice S.A Asset Resilience Ratio by Year (2017–2023)
Medinice S.A asset resilience ratio by year from 2017 to 2023. The table below shows the annual Asset Resilience Ratio data for Medinice S.A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.01% | zł3.00K ≈ $825.64 |
zł37.49 Million ≈ $10.32 Million |
-1.50pp |
| 2022-12-31 | 1.50% | zł630.00K ≈ $173.39K |
zł41.90 Million ≈ $11.53 Million |
+1.35pp |
| 2021-12-31 | 0.15% | zł75.00K ≈ $20.64K |
zł49.18 Million ≈ $13.53 Million |
+0.05pp |
| 2020-12-31 | 0.11% | zł22.00K ≈ $6.05K |
zł20.92 Million ≈ $5.76 Million |
-0.12pp |
| 2019-12-31 | 0.22% | zł25.95K ≈ $7.14K |
zł11.68 Million ≈ $3.22 Million |
+0.09pp |
| 2018-12-31 | 0.13% | zł10.00K ≈ $2.75K |
zł7.55 Million ≈ $2.08 Million |
+1.87pp |
| 2017-12-31 | -1.74% | zł-85.17K ≈ $-23.44K |
zł4.90 Million ≈ $1.35 Million |
-- |
About Medinice S.A
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technol… Read more